| Home > Women's Health > |
| Home > Women's Health > |
A federal advisory panel is recommending that a new vaccine for human papilloma virus (HPV) be routinely given to girls aged 11-12. The Advisory Committee on Immunization Practices also said the vaccine, called Gardasil, may be given to girls as young as 9, if doctors think it's necessary.
Gardasil, made by Merck, was approved earlier this month by the US Food and Drug Administration. It protects against 2 strains of HPV that are responsible for about 70% of cases of cervical cancer, and also some cases of vaginal, vulvar, penile, and anal cancers. The vaccine also targets 2 other HPV strains responsible for 90% of genital warts cases.
The committee's action "represents another critical step toward preventing cervical cancer and saving the lives of women in this country and around the world," said Debbie Saslow, PhD, director of breast and gynecologic cancers at the American Cancer Society. "The Society encourages widespread vaccination to protect adolescent girls from the 2 most common cancer-causing types of HPV."
|
Top Stories
WEDNESDAY, July 5 (HealthDay News) -- Female survivors of childhood cancer are more li
Most women in the dark about HPVOnly 40 percent had heard of sexually transmitted diseas
Eating red meat may raise breast cancer riskTaking vitamins won't protect against heart
Tighter rules on trendy hormones urgedClaims touting anti-aging 'bioidenticals' are wron
Brazilian model dies from anorexia21-year-old Ana Carolina Reston weighed 88 poundsL'Equ
Amniocentesis doesn't raise miscarriage rateOlder studies overestimated risk, new report
|
|
Related
TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called ar (HealthDay News) -- While many women take birth control pills without incident, these d MONDAY, Feb. 12 (HealthDay News) -- Extensive genetic analysis has uncovered a gene var MONDAY, Feb. 12 (HealthDay News) -- Postmenopausal breast cancer patients who switch f
FRIDAY, Feb. 9 (HealthDay News) -- A neuropeptide called melanin concentrating hormone
WEDNESDAY, Feb. 7 (HealthDay News) -- A new monoclonal antibody drug produced dramatic
TUESDAY, Feb. 13 (HealthDay News) -- Many patients with moderate to severe chronic psor
FRIDAY, Feb. 2 (HealthDay News) -- People who spend a lot of time behind the wheel may
|

